Jim Lu is the founder of TriArm Therapeutics. TriArm Therapeutics has raised $60M in total funding. Latest round: Series A. Based in Shanghai, China.
Jim Lu is associated with TriArm Therapeutics, a company founded in 2018 focused on developing cellular immunotherapy products for cancer treatment. TriArm Therapeutics specializes in the research and clinical transformation of CD19 CAR-T product using non-viral gene transfer technology.
Full founder directory · Investor directory · Company funding database · Fundraising library